Fresenius SE Comprehensive Income 2016-2024 | FSNUY

Fresenius SE comprehensive income from 2016 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
  • Fresenius SE comprehensive income for the quarter ending June 30, 2024 was $0.274B, a 128.05% increase year-over-year.
  • Fresenius SE comprehensive income for 2023 was $0.019B, a 95.46% decline from 2022.
  • Fresenius SE comprehensive income for 2022 was $0.429B, a 181.27% decline from 2021.
  • Fresenius SE comprehensive income for 2021 was $-0.528B, a 59.3% decline from 2020.
Fresenius SE Annual Comprehensive Income
(Millions of US $)
2023 $19
2022 $429
2021 $-528
2020 $-1,297
2019 $-213
2018 $-390
2017 $-450
2016 $580
2015 $311
Fresenius SE Quarterly Comprehensive Income
(Millions of US $)
2024-06-30 $274
2024-03-31 $182
2023-12-31 $19
2023-09-30 $468
2023-06-30 $120
2023-03-31 $157
2022-12-31 $429
2022-09-30 $1,675
2022-06-30 $809
2022-03-31 $-1
2021-12-31 $-528
2021-09-30 $-746
2021-06-30 $-972
2021-03-31 $-857
2020-12-31 $-1,297
2020-09-30 $-892
2020-06-30 $-282
2020-03-31 $-163
2019-12-31 $-213
2019-09-30 $170
2019-06-30 $-255
2019-03-31 $-179
2018-12-31 $-390
2018-09-30 $-464
2018-06-30 $-464
2018-03-31 $-766
2017-12-31 $-450
2017-09-30 $-375
2017-06-30 $-59
2017-03-31 $607
2016-12-31 $580
2016-09-30 $232
2016-06-30 $241
2016-03-31 $29
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.458B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00